These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9704489)

  • 21. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen.
    MMWR Recomm Rep; 1996 Mar; 45(RR-2):1-9. PubMed ID: 8604210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In the NAT era, is routine lookback to recipients still required when donors seroconvert for HIV infection?
    Vishram B; Reynolds C; Brailsford SR; Hewitt P
    Vox Sang; 2019 May; 114(4):394-396. PubMed ID: 30820949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAT screening of blood and plasma donations: evolution of technology and regulatory policy.
    Tabor E; Epstein JS
    Transfusion; 2002 Sep; 42(9):1230-7. PubMed ID: 12430684
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of blood-borne HIV transmission using a decentralized approach in Shaba, Zaire.
    Laleman G; Magazani K; Perriëns JH; Badibanga N; Kapila N; Konde M; Selemani U; Piot P
    AIDS; 1992 Nov; 6(11):1353-8. PubMed ID: 1472338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood Donor Test-Seeking Motivation and Prior HIV Testing Experiences in São Paulo, Brazil.
    Truong HM; Blatyta PF; Santos FM; Montebello S; Esposti SP; Hangai FN; Salles NA; Mendrone A; Sabino EC; McFarland W; Gonçalez TT
    AIDS Behav; 2015 Sep; 19(9):1574-8. PubMed ID: 25795320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security].
    Nébié KY; Olinger CM; Kafando E; Dahourou H; Diallo S; Kientega Y; Domo Y; Kienou K; Ouattara S; Sawadogo I; Ky L; Muller CP
    Transfus Clin Biol; 2007 Nov; 14(5):446-52. PubMed ID: 18295528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The impact of the implementation of staying in the United Kingdom for six months or more as donor exclusion criteria on the donor base of the Basque Country].
    Pérez Vaquero MA; Basaldua MA; Ibarra A; Renovales A; Larrea A; Vesga MA
    Med Clin (Barc); 2001 Mar; 116(11):413-5. PubMed ID: 11333688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of AIDS transmission through screening of the blood supply.
    Galel SA; Lifson JD; Engleman EG
    Annu Rev Immunol; 1995; 13():201-27. PubMed ID: 7612221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transfusion-transmitted viruses in blood transfusion.
    Luban NL; Jubran RF
    Adv Exp Med Biol; 2001; 489():1-12. PubMed ID: 11554584
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 36. [Residual risk of human immunodeficiency virus infection in blood banks. Impact of screening with nucleic acid tests].
    Machuca A; Hewlett I
    Med Clin (Barc); 2003 Oct; 121(11):418-25. PubMed ID: 14563274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors.
    Salles NA; Sabino EC; Cliquet MG; Eluf-Neto J; Mayer A; Almeida-Neto C; Mendonça MC; Dorliach-Llacer P; Chamone DF; Saéz-Alquézar A
    Transfusion; 1996; 36(11-12):969-73. PubMed ID: 8937406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of improved safety on maintaining a sufficient blood supply.
    Reynolds E; Wickenden C; Oliver A
    Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ten years of nucleic acid testing: lessons and prospects].
    Morel P
    Transfus Clin Biol; 2011 Apr; 18(2):133-9. PubMed ID: 21397544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.